Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT5 | Q9NXA8 | 5/20 | 0.57 |
| ▸ | SIRT2 | Q8IXJ6 | 11/20 | 0.54 |
| ▸ | SIRT1 | Q96EB6 | 10/20 | 0.54 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.54 |
| ▸ | TGM2 | P21980 | 1/20 | 0.53 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10943848 | 0.99 | SIRT5 (0.56) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| Hydrochloric Acid SCHEMBL10884941 | 0.99 | SIRT5 (0.56) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| SCHEMBL17289476 | 0.98 | SIRT5 (0.55) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| SCHEMBL2193250 | 0.95 | SSTR3 (0.57) | SIRT5SIRT2SIRT1SIRT3SSTR3 | |
| SCHEMBL14286269 | 0.94 | SIRT5 (0.51) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| SCHEMBL236067 | 0.94 | SIRT5 (0.51) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| SCHEMBL14264834 | 0.94 | SIRT5 (0.51) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| Hydrochloric Acid SCHEMBL3503087 | 0.94 | SIRT5 (0.51) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| Hydrochloric Acid SCHEMBL10946482 | 0.93 | SIRT2 (0.49) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| Hydrochloric Acid SCHEMBL10960457 | 0.93 | SIRT2 (0.49) | SIRT5SIRT2SIRT1SIRT3TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8309788-B2 | Protease inhibitors in absorbent articles | THE PROCTER AND GAMBLE COMPANY (US) | 2012-11-13 | — | — | US | disclosed |
| US-8244484-B2 | Proteome epitope tags and methods of use thereof in protein modification analysis | EMD MILLIPORE CORPORATION (US) | 2012-08-14 | — | — | US | disclosed |
| US-8003362-B2 | Methods and constructs for high yield expression of clostripain | MEDTRONIC INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-20100331200-A1 | POST TRANSLATIONAL MODIFICATION PATTERN ANALYSIS | MILLIPORE CORPORATION | 2010-12-30 | — | — | US | disclosed |
| US-7855057-B2 | Protein splice variant/isoform discrimination and quantitative measurements thereof | MILLIPORE CORPORATION (US) | 2010-12-21 | — | — | US | disclosed |
| US-20100184613-A1 | Proteome Epitope Tags and Methods of Use Thereof in Protein Modification Analysis | MILLIPORE CORPORATION (US) | 2010-07-22 | — | — | US | disclosed |
| US-7645586-B2 | Protein isoform discrimination and quantitative measurements thereof | MILLIPORE CORPORATION (US) | 2010-01-12 | — | — | US | disclosed |
| EP-1521767-B1 | METHODS AND CONSTRUCTS FOR HIGH YIELD EXPRESSION OF CLOSTRIPAIN | RESTORAGEN INC (US) | 2009-12-16 | — | — | EP | disclosed |
| US-7618788-B2 | Proteome epitope tags and methods of use thereof in protein modification analysis | MILLIPORE CORPORATION (US) | 2009-11-17 | — | — | US | disclosed |
| US-20090131890-A1 | PROTEASE INHIBITORS IN ABSORBENT ARTICLES | ROURKE FRANCIS JAMES | 2009-05-21 | — | — | US | disclosed |
| EP-1061963-B1 | PROTEASE INHIBITORS IN ABSORBENT ARTICLES | PROCTER & GAMBLE (US) | 2003-05-07 | — | — | EP | disclosed |
| EP-1128725-B1 | DISPOSABLE PREMOISTENED WIPE CONTAINING AN ANTIMICROBIAL PROTEASE INHIBITOR | PROCTER & GAMBLE (US) | 2003-03-26 | — | — | EP | disclosed |
| EP-1128725-A1 | DISPOSABLE PREMOISTENED WIPE CONTAINING AN ANTIMICROBIAL PROTEASE INHIBITOR | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-05 | — | — | EP | disclosed |
| US-6207596-B1 | AROMATIC DIAMIDINE | THE PROCTER & GAMBLE COMPANY | 2001-03-27 | — | — | US | disclosed |
| EP-1061962-A1 | DISPOSABLE ABSORBENT ARTICLE HAVING A SKIN CARE COMPOSITION CONTAINING AN ENZYME INHIBITOR | THE PROCTER & GAMBLE COMPANY (US) | 2000-12-27 | — | — | EP | disclosed |
| WO-2000027191-A1 | DISPOSABLE PREMOISTENED WIPE CONTAINING AN ANTIMICROBIAL PROTEASE INHIBITOR | THE PROCTER & GAMBLE COMPANY (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-1999045973-A1 | DISPOSABLE ABSORBENT ARTICLE HAVING A SKIN CARE COMPOSITION CONTAINING AN ENZYME INHIBITOR | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-16 | — | — | WO | disclosed |
| EP-0329693-A4 | HUMAN PANCREATIC SECRETORY TRYPSIN INHIBITORS PRODUCED BY RECOMBINANT DNA METHODS AND PROCESSES FOR THE PRODUCTION OF SAME. | SYNERGEN BIOLOG INC (US) | 1989-09-26 | — | — | EP | disclosed |
| EP-0329693-A1 | HUMAN PANCREATIC SECRETORY TRYPSIN INHIBITORS PRODUCED BY RECOMBINANT DNA METHODS AND PROCESSES FOR THE PRODUCTION OF SAME | SYNERGEN BIOLOGICALS, INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| WO-1988003171-A1 | HUMAN PANCREATIC SECRETORY TRYPSIN INHIBITORS PRODUCED BY RECOMBINANT DNA METHODS AND PROCESSES FOR THE PRODUCTION OF SAME | SYNERGEN BIOLOGICALS, INC. (US) | 1988-05-05 | — | — | WO | disclosed |